# FHND9041 Versus Afatinib for Non-small Cell Lung Cancer

Source: https://onco.cc/trials/nct06759857/  
OnCo record `nct06759857` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of afatinib in lung cancer, run by Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., now recruiting.

## Summary

FHND9041 Versus Afatinib for Non-small Cell Lung Cancer is a phase 3, randomised interventional study registered as NCT06759857 by Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., with a registry enrolment figure of 350 participants, started 2021-08-01 and due to reach its primary completion in 2025-03-04. Interventions recorded: FHND9041; Afatinib. Conditions listed: Non Small Cell Lung Cancer. Primary outcome: Progression-Free Survival (PFS). Lung eligibility wording from the registry: "* Histologically or cytologically confirmed diagnosis of locally advanced or metastatic non-small cell lung cancer (NSCLC), including patients with recurrent disease following prior surgical treatment or newly diagnosed Stage IIIb, IIIc, or IV NSCLC (staging based on the 8th edition of the AJCC guid". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-25
- Also known as: FHND9041
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT06759857
- Phase: 3
- Setting: A Randomized, Open, Positives Parallel-controlled, Multicenter Phase III to Evaluate the Efficacy and Safety of FHND9041 Versus Afatinib in First-line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer
- Sponsor: Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
- Enrolled: 350

## Sources

- ClinicalTrials.gov NCT06759857: https://clinicaltrials.gov/study/NCT06759857

## Connected records

- cancers: [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- technologies: [Small-molecule kinase inhibitors](https://onco.cc/technologies/kinase-inhibitors/)
- drugs: [Afatinib](https://onco.cc/drugs/afatinib/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06759857.json